Eton Pharmaceuticals (ETON) Net Shares Issued and Repurchased (2018 - 2025)

Eton Pharmaceuticals has disclosed Net Shares Issued and Repurchased across 8 years of filings, most recently posting $471059.0 for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased fell 70.94% year-over-year to $471059.0; the TTM figure through Dec 2025 stood at $471059.0 (down 70.94% YoY), while the FY2025 annual figure was $471059.0, down 70.94% from the prior year.
• Net Shares Issued and Repurchased came in at $471059.0 for Q4 2025 at Eton Pharmaceuticals, up from $445084.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.6 million in Q4 2024 to a low of $130000.0 in Q1 2021.
• Average Net Shares Issued and Repurchased over 5 years is $934536.6, with a median of $1.1 million recorded in 2023.
• Year-over-year, Net Shares Issued and Repurchased sank 88.91% in 2021 and surged 764.44% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $1.0 million in 2021, then grew by 10.49% to $1.1 million in 2022, then decreased by 1.38% to $1.1 million in 2023, then surged by 46.27% to $1.6 million in 2024, then plunged by 70.94% to $471059.0 in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $471059.0 in Q4 2025, $445084.0 in Q1 2025, and $1.6 million in Q4 2024.